David A. Siegel Century Therapeutics, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPSC
# of Institutions
67Shares Held
36.9MCall Options Held
8.7KPut Options Held
10.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$9.31 Million1.66% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$9.27 Million0.95% of portfolio
-
Boxer Capital, LLC San Diego, CA3.9MShares$6.71 Million0.35% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$5.53 Million0.43% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$4.98 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $101M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...